BioVie Inc. Operating Expenses
BioVie Inc. (BIVI) reported Operating Expenses of $22.65 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- BioVie Inc. operating expenses for the quarter ending 2026-06-30 was $5.72M, a 56.14% increase year-over-year.
- BioVie Inc. operating expenses for the quarter ending 2026-03-31 was $5.39M, a 80.22% increase year-over-year.
- BioVie Inc. operating expenses for the quarter ending 2025-12-31 was $6.26M, a 14.13% decline year-over-year.
- BioVie Inc. operating expenses for the quarter ending 2025-09-30 was $5.28M, a 28.20% increase year-over-year.
- BioVie Inc. operating expenses for fiscal 2026 was $22.65M, a 25.38% increase from fiscal 2025.
- BioVie Inc. operating expenses for fiscal 2025 was $18.07M.
- BioVie Inc. operating expenses for fiscal 2023 was $45.08M, a 65.41% increase from fiscal 2022.
- BioVie Inc. operating expenses for fiscal 2022 was $27.25M, a 80.26% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.72M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $11.10M derived: sum of 2 quarters · filed 2026-08-13 | $17.37M derived: sum of 3 quarters · filed 2026-08-13 | $22.65M 10-K · filed 2026-08-13 | ||
| 2026-03-31 | $5.39M S-1/A · filed 2026-08-06 | $11.65M derived: sum of 2 quarters · filed 2026-08-06 | $16.93M S-1/A · filed 2026-08-06 | $20.60M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $6.26M 10-Q · filed 2026-02-06 | $11.55M 10-Q · filed 2026-02-06 | $15.21M derived: sum of 3 quarters · filed 2026-08-13 | $18.20M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-09-30 | $5.28M 10-Q · filed 2025-11-10 | $8.95M derived: sum of 2 quarters · filed 2026-08-13 | $11.94M derived: sum of 3 quarters · filed 2026-08-13 | $19.23M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $3.66M derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $6.65M derived: sum of 2 quarters · filed 2026-08-13 | $13.94M derived: sum of 3 quarters · filed 2026-08-13 | $18.07M 10-K · filed 2026-08-13 | ||
| 2025-03-31 | $2.99M S-1/A · filed 2026-08-06 | $10.28M derived: sum of 2 quarters · filed 2026-08-06 | $14.40M S-1/A · filed 2026-08-06 | $19.19M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2024-12-31 | $7.29M 10-Q · filed 2026-02-06 | $11.41M 10-Q · filed 2026-02-06 | $16.21M derived: sum of 3 quarters · filed 2026-08-06 | $23.94M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2024-09-30 | $4.12M 10-Q · filed 2025-11-10 | $8.91M derived: sum of 2 quarters · filed 2026-08-06 | $16.64M derived: sum of 3 quarters · filed 2026-08-06 | $25.43M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2024-06-30 | $4.79M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $12.52M derived: sum of 2 quarters · filed 2026-08-06 | $21.30M derived: sum of 3 quarters · filed 2026-08-06 | $32.18M S-1/A · filed 2026-08-06 | ||
| 2024-03-31 | $7.73M 10-Q · filed 2025-05-12 | $16.51M derived: sum of 2 quarters · filed 2025-05-12 | $27.39M 10-Q · filed 2025-05-12 | $38.37M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $8.78M 10-Q · filed 2025-02-11 | $19.66M 10-Q · filed 2025-02-11 | $30.63M derived: sum of 3 quarters · filed 2025-02-11 | $44.41M derived: sum of 4 quarters · filed 2025-02-11 | ||
| 2023-09-30 | $10.88M 10-Q · filed 2024-11-13 | $21.85M derived: sum of 2 quarters · filed 2024-11-13 | $35.63M derived: sum of 3 quarters · filed 2024-11-13 | $47.12M derived: sum of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $10.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $24.75M derived: sum of 2 quarters · filed 2024-09-30 | $36.25M derived: sum of 3 quarters · filed 2024-09-30 | $45.08M 10-K · filed 2024-09-30 | ||
| 2023-03-31 | $13.77M 10-Q · filed 2024-05-14 | $25.27M derived: sum of 2 quarters · filed 2024-05-14 | $34.10M 10-Q · filed 2024-05-14 | $43.40M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $11.49M 10-Q · filed 2024-02-13 | $20.33M 10-Q · filed 2024-02-13 | $29.62M derived: sum of 3 quarters · filed 2024-02-13 | $35.37M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-09-30 | $8.83M 10-Q · filed 2023-11-08 | $18.13M derived: sum of 2 quarters · filed 2023-11-08 | $23.88M derived: sum of 3 quarters · filed 2023-11-08 | $30.54M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $9.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $15.04M derived: sum of 2 quarters · filed 2023-08-16 | $21.71M derived: sum of 3 quarters · filed 2023-08-16 | $27.25M 10-K · filed 2023-08-16 | ||
| 2022-03-31 | $5.75M 10-Q · filed 2023-05-12 | $12.41M derived: sum of 2 quarters · filed 2023-05-12 | $17.96M 10-Q · filed 2023-05-12 | $149.56M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $6.67M 10-Q · filed 2023-02-10 | $12.21M 10-Q · filed 2023-02-10 | $143.81M derived: sum of 3 quarters · filed 2023-02-10 | $146.82M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-09-30 | $5.55M 10-Q · filed 2022-11-04 | $137.15M derived: sum of 2 quarters · filed 2022-11-04 | $140.15M derived: sum of 3 quarters · filed 2022-11-04 | $143.21M derived: sum of 4 quarters · filed 2022-11-04 | ||
| 2021-06-30 | $131.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $134.60M derived: sum of 2 quarters · filed 2022-09-27 | $137.67M derived: sum of 3 quarters · filed 2022-09-27 | $138.05M 10-K · filed 2022-09-27 | ||
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-11 | $6.06M derived: sum of 2 quarters · filed 2022-05-11 | $6.45M 10-Q · filed 2022-05-11 | $7.03M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $3.06M 10-Q · filed 2022-02-08 | $3.45M 10-Q · filed 2022-02-08 | $4.03M derived: sum of 3 quarters · filed 2022-02-08 | $4.73M derived: sum of 4 quarters · filed 2022-02-08 | ||
| 2020-09-30 | $386.75K 10-Q · filed 2021-11-10 | $963.73K derived: sum of 2 quarters · filed 2021-11-10 | $1.66M derived: sum of 3 quarters · filed 2021-11-10 | $2.37M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $576.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $1.28M derived: sum of 2 quarters · filed 2021-08-30 | $1.99M derived: sum of 3 quarters · filed 2021-08-30 | $2.69M 10-K · filed 2021-08-30 | ||
| 2020-03-31 | $699.25K 10-Q · filed 2021-05-10 | $1.41M derived: sum of 2 quarters · filed 2021-05-10 | $2.12M 10-Q · filed 2021-05-10 | $2.77M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $710.45K 10-Q · filed 2021-01-29 | $1.42M 10-Q · filed 2021-01-29 | $2.07M derived: sum of 3 quarters · filed 2021-01-29 | $2.92M derived: sum of 4 quarters · filed 2021-01-29 | ||
| 2019-09-30 | $706.22K 10-Q · filed 2020-11-05 | $1.36M derived: sum of 2 quarters · filed 2020-11-05 | $2.21M derived: sum of 3 quarters · filed 2020-11-05 | $2.71M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $655.99K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $1.50M derived: sum of 2 quarters · filed 2020-08-07 | $2.01M derived: sum of 3 quarters · filed 2020-08-07 | $2.50M 10-K/A · filed 2020-08-07 | ||
| 2019-03-31 | $848.29K 10-Q · filed 2020-05-13 | $1.35M derived: sum of 2 quarters · filed 2020-05-13 | $1.84M 10-Q · filed 2020-05-13 | $2.36M derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $500.87K 10-Q · filed 2020-02-13 | $992.30K 10-Q · filed 2020-02-13 | $992.30K 10-Q · filed 2019-02-12 | $1.52M derived: sum of 3 quarters · filed 2020-02-13 | $2.21M derived: sum of 4 quarters · filed 2020-02-13 | |
| 2018-09-30 | $491.43K 10-Q · filed 2019-11-19 | $1.02M derived: sum of 2 quarters · filed 2019-11-19 | $1.71M derived: sum of 3 quarters · filed 2019-11-19 | $2.20M derived: sum of 4 quarters · filed 2019-11-19 | ||
| 2018-06-30 | $523.91K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $1.22M derived: sum of 2 quarters · filed 2019-09-27 | $1.71M derived: sum of 3 quarters · filed 2019-09-27 | $2.37M 10-K · filed 2019-09-27 | ||
| 2018-03-31 | $691.22K 10-Q · filed 2019-05-10 | $1.19M derived: sum of 2 quarters · filed 2019-05-10 | $1.85M 10-Q · filed 2019-05-10 | $2.29M derived: sum of 4 quarters · filed 2019-05-10 | ||
| 2017-12-31 | $494.81K 10-Q · filed 2019-02-12 | $1.16M 10-Q · filed 2019-02-12 | $1.16M 10-Q · filed 2018-02-14 | $1.60M derived: sum of 3 quarters · filed 2019-02-12 | $2.00M derived: sum of 4 quarters · filed 2019-02-12 | |
| 2017-09-30 | $662.23K 10-Q · filed 2018-11-14 | $662.23K 10-Q · filed 2017-11-08 | $1.11M derived: sum of 2 quarters · filed 2018-11-14 | $1.51M derived: sum of 3 quarters · filed 2018-11-14 | $1.86M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $443.93K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $844.46K derived: sum of 2 quarters · filed 2018-10-05 | $1.20M derived: sum of 3 quarters · filed 2018-10-05 | $1.55M 10-K · filed 2018-10-05 | ||
| 2017-03-31 | $400.53K 10-Q · filed 2018-05-14 | $758.33K derived: sum of 2 quarters · filed 2018-05-14 | $1.11M 10-Q · filed 2018-05-14 | $1.38M derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $357.80K 10-Q · filed 2018-02-14 | $709.15K 10-Q · filed 2018-02-14 | $978.77K derived: sum of 3 quarters · filed 2018-02-14 | $1.04M derived: sum of 4 quarters · filed 2018-02-14 | ||
| 2016-09-30 | $351.35K 10-Q · filed 2017-11-08 | $620.97K derived: sum of 2 quarters · filed 2017-11-08 | $678.83K derived: sum of 3 quarters · filed 2017-11-08 | $728.75K derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | $269.62K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | $327.47K derived: sum of 2 quarters · filed 2017-08-24 | $377.40K derived: sum of 3 quarters · filed 2017-08-24 | $432.03K 10-K · filed 2017-08-24 | ||
| 2016-03-31 | $57.85K 10-Q · filed 2017-05-09 | $107.78K derived: sum of 2 quarters · filed 2017-05-09 | $162.41K 10-Q · filed 2017-05-09 | $217.26K derived: sum of 4 quarters · filed 2017-05-09 | ||
| 2015-12-31 | $49.93K 10-Q · filed 2017-02-07 | $49.93K 10-Q · filed 2016-02-16 | $104.56K 10-Q · filed 2017-02-07 | $159.41K derived: sum of 3 quarters · filed 2017-02-07 | $208.45K derived: sum of 4 quarters · filed 2017-02-07 | |
| 2015-09-30 | $54.63K 10-Q/A · filed 2017-01-19 | $109.48K derived: sum of 2 quarters · filed 2017-01-19 | $158.52K derived: sum of 3 quarters · filed 2017-01-19 | $229.11K derived: sum of 4 quarters · filed 2017-01-19 | ||
| 2015-06-30 | $54.85K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $103.90K derived: sum of 2 quarters · filed 2016-09-28 | $174.49K derived: sum of 3 quarters · filed 2016-09-28 | $233.38K 10-K · filed 2016-09-28 | ||
| 2015-03-31 | $49.04K 10-Q · filed 2016-05-23 | $119.63K derived: sum of 2 quarters · filed 2016-05-23 | $178.52K 10-Q · filed 2016-05-23 | $351.87K derived: sum of 4 quarters · filed 2016-05-23 | ||
| 2014-12-31 | $70.59K 10-Q · filed 2016-02-16 | $129.48K 10-Q · filed 2016-02-16 | $302.83K derived: sum of 3 quarters · filed 2016-02-16 | $351.00K derived: sum of 4 quarters · filed 2016-02-16 | ||
| 2014-09-30 | $58.89K 10-Q · filed 2015-11-13 | $232.24K derived: sum of 2 quarters · filed 2015-11-13 | $280.41K derived: sum of 3 quarters · filed 2015-11-13 | $327.69K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $173.35K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-01 | $221.52K derived: sum of 2 quarters · filed 2015-10-01 | $268.80K derived: sum of 3 quarters · filed 2015-10-01 | $322.38K 10-K · filed 2015-10-01 | ||
| 2014-03-31 | $48.17K 10-Q · filed 2015-05-11 | $95.45K derived: sum of 2 quarters · filed 2015-05-11 | $149.04K 10-Q · filed 2015-05-11 | $166.55K 10-Q · filed 2014-05-09 | ||
| 2013-12-31 | $47.28K 10-Q · filed 2015-02-05 | $100.86K 10-Q · filed 2015-02-05 | $118.38K 10-Q · filed 2014-01-29 | |||
| 2013-09-30 | $53.58K 10-Q · filed 2014-11-13 | $71.10K 10-Q · filed 2013-11-13 | ||||
| 2013-06-30 | $17.52K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |